| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |